| What is the value of reactive case detection in malaria control? A case-study in India and a systematic review AM Van Eijk, L Ramanathapuram, PL Sutton, D Kanagaraj, ... Malaria journal 15, 1-13, 2016 | 69 | 2016 |
| The burden of submicroscopic and asymptomatic malaria in India revealed from epidemiology studies at three varied transmission sites in India AM van Eijk, PL Sutton, L Ramanathapuram, SA Sullivan, D Kanagaraj, ... Scientific reports 9 (1), 17095, 2019 | 64 | 2019 |
| Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases NK Garg, N Tandel, SK Bhadada, RK Tyagi Frontiers in pharmacology 12, 713616, 2021 | 52 | 2021 |
| Lipid–polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions NK Garg, N Tandel, RS Jadon, RK Tyagi, OP Katare Drug discovery today 23 (9), 1610-1621, 2018 | 45 | 2018 |
| The use of mosquito repellents at three sites in India with declining malaria transmission: surveys in the community and clinic AM Van Eijk, L Ramanathapuram, PL Sutton, N Peddy, S Choubey, ... Parasites & vectors 9, 1-13, 2016 | 43 | 2016 |
| Translating treg therapy for inflammatory bowel disease in humanized mice S Negi, S Saini, N Tandel, K Sahu, RPN Mishra, RK Tyagi Cells 10 (8), 1847, 2021 | 40 | 2021 |
| Humanized Mice Are Instrumental to the Study of Plasmodium falciparum Infection RK Tyagi, N Tandel, R Deshpande, RW Engelman, SD Patel, P Tyagi Frontiers in Immunology 9, 2550, 2018 | 36 | 2018 |
| Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays S Uplekar, PN Rao, L Ramanathapuram, V Awasthi, K Verma, P Sutton, ... PLoS neglected tropical diseases 11 (1), e0005323, 2017 | 31 | 2017 |
| Understanding mutations in human SARS-CoV-2 spike glycoprotein: a systematic review & meta-analysis R Kumar, Y Srivastava, P Muthuramalingam, SK Singh, G Verma, S Tiwari, ... Viruses 15 (4), 856, 2023 | 30 | 2023 |
| The molecular targets of swertiamarin and its derivatives confer anti-diabetic and anti-hyperlipidemic effects N Patel, RK Tyagi, N Tandel, NK Garg, N Soni Current Drug Targets 19 (16), 1958-1967, 2018 | 30 | 2018 |
| Transdermal Immunization of Elastic Liposome-Laden Recombinant Chimeric Fusion Protein of P. falciparum (PfMSP-Fu24) Mounts Protective Immune Response R Chaudhari, N Tandel, K Sahu, S Negi, H Bashir, A Rupareliya, ... Nanomaterials 11 (2), 406, 2021 | 20 | 2021 |
| Aceclofenac and methotrexate combination therapy could influence Th1/Th17 axis to modulate rheumatoid-arthritis-induced inflammation S Negi, N Tandel, P Sharma, R Kumar, RK Tyagi Drug discovery today 28 (8), 103671, 2023 | 16 | 2023 |
| Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy RS Jadon, G Sharma, NK Garg, N Tandel, KR Gajbhiye, R Salve, ... Colloids And Surfaces B: Biointerfaces 203, 111760, 2021 | 12 | 2021 |
| An evaluation of liposome-based diagnostics of pulmonary and extrapulmonary tuberculosis N Tandel, AZ Joseph, A Joshi, P Shrama, RPN Mishra, RK Tyagi, ... Expert review of molecular diagnostics 20 (5), 533-541, 2020 | 7 | 2020 |
| Co-delivery of aceclofenac and methotrexate nanoparticles presents an effective treatment for rheumatoid arthritis S Negi, N Tandel, NK Garg, P Sharma, R Kumar, P Sharma, R Kumar, ... International Journal of Nanomedicine, 2149-2177, 2024 | 5 | 2024 |
| Role of natural killer and B cell interaction in inducing pathogen specific immune responses N Tandel, S Negi, SK Dalai, RK Tyagi International Reviews of Immunology 42 (4), 304-322, 2023 | 5 | 2023 |
| NKB cells: A double-edged sword against inflammatory diseases N Tandel, S Negi, RK Tyagi Frontiers in Immunology 13, 972435, 2022 | 5 | 2022 |
| Oleuropein activates autophagy to circumvent anti-plasmodial defense P Sharma, N Tandel, R Kumar, S Negi, P Sharma, S Devi, K Saxena, ... Iscience 27 (4), 2024 | 4 | 2024 |
| RNA-loaded dendritic cells: more than a tour de force in cancer therapeutics A Joshi, N Tandel, P Tyagi, SK Dalai, PS Bisen, RK Tyagi Immunotherapy 11 (13), 1129-1147, 2019 | 4 | 2019 |
| Poly (I: C) and R848 ligands show better adjuvanticity to induce B and T cell responses against the antigen (s) N Tandel, D Patel, M Thakkar, J Shah, RK Tyagi, SK Dalai Heliyon 10 (5), 2024 | 3 | 2024 |